HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation.
Host cells impose a broad range of obstacles to the replication of retroviruses. Tetherin (also known as CD317, BST-2 or HM1.24) impedes viral release by retaining newly budded HIV-1 virions on the surface of cells. HIV-1 Vpu efficiently counteracts this restriction. Here, we show that HIV-1 Vpu ind...
Guardado en:
Autores principales: | Bastien Mangeat, Gustavo Gers-Huber, Martin Lehmann, Madeleine Zufferey, Jeremy Luban, Vincent Piguet |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/44a0c442744b443baf920336e2d7e616 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2.
por: Bin Jia, et al.
Publicado: (2009) -
BST2/Tetherin enhances entry of human cytomegalovirus.
por: Kasinath Viswanathan, et al.
Publicado: (2011) -
The great escape: viral strategies to counter BST-2/tetherin.
por: Janet L Douglas, et al.
Publicado: (2010) -
BST2/tetherin inhibits dengue virus release from human hepatoma cells.
por: Xiao-Ben Pan, et al.
Publicado: (2012) -
Stability of the PHF10 subunit of PBAF signature module is regulated by phosphorylation: role of β-TrCP
por: Victor V. Tatarskiy, et al.
Publicado: (2017)